JECX.JK Nitrasanata Dharma Tbk

Healthcare Medical Care Facilities Jakarta Exchange
1,110 IDR
Close of Oct 29, 2026
Market cap
IDR 3.61T
P/E
58.6x
P/B
6.78x
ROE
10.9%
Dividend yield
1.74%
Fundamental score
1.4/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is JECX.JK undervalued?

Graham number

The Graham number of Nitrasanata Dharma Tbk cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nitrasanata Dharma Tbk fundamental analysis

7 of 22 checks passed

ROE 1/2

Moderate return on equity (12.7%), between 10% and 20%.

ROA 1/1

Return on assets (4.7%) is above the industry median (2.5%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (16.0%) is below the industry median (28.6%).

Revenue Growth 0/2

Revenue did not grow over the past 3 years or is not reported.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (33.6%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is 4.8x against interest expense, below 5x.

PE vs Market 0/1

PE (62.9x) is above the market median (12.0x).

PE vs Industry 0/1

PE (62.9x) is above the industry median (27.5x).

PBV 0/1

Price to book (7.3x) is above the industry median (5.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 457.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.6%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 86.8%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Nitrasanata Dharma Tbk stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nitrasanata Dharma Tbk

PT Nitrasanata Dharma operates as a provider of eye health services in Indonesia. The company provides ophthalmic services including cataract, lens and refractive surgery, glaucoma treatment, retina care, okuloplasty and orbital reconstruction, pediatric ophthalmology and strabismus management, contact lens services, infection and immunology care, neuro-ophthalmology, dry eye treatment, and ophthalmic trauma services. In addition, it offers solutions, such as eye check diagn…

Full company profile